These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28450396)

  • 21. Inhibiting spinal cord-specific hsp90 isoforms reveals a novel strategy to improve the therapeutic index of opioid treatment.
    Duron DI; Tanguturi P; Campbell CS; Chou K; Bejarano P; Gabriel KA; Bowden JL; Mishra S; Brackett C; Barlow D; Houseknecht KL; Blagg BSJ; Streicher JM
    Sci Rep; 2024 Jun; 14(1):14715. PubMed ID: 38926482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
    Al Shaer L; Walsby E; Gilkes A; Tonks A; Walsh V; Mills K; Burnett A; Rowntree C
    Br J Haematol; 2008 May; 141(4):483-93. PubMed ID: 18373709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells.
    Wang B; Chen L; Ni Z; Dai X; Qin L; Wu Y; Li X; Xu L; Lian J; He F
    Exp Cell Res; 2014 Nov; 328(2):379-87. PubMed ID: 25196280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
    J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
    Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
    Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.
    Solit DB; Osman I; Polsky D; Panageas KS; Daud A; Goydos JS; Teitcher J; Wolchok JD; Germino FJ; Krown SE; Coit D; Rosen N; Chapman PB
    Clin Cancer Res; 2008 Dec; 14(24):8302-7. PubMed ID: 19088048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation.
    Koga F; Xu W; Karpova TS; McNally JG; Baron R; Neckers L
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11318-22. PubMed ID: 16844778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
    Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
    J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.
    Hutchinson MR; Ramos KM; Loram LC; Wieseler J; Sholar PW; Kearney JJ; Lewis MT; Crysdale NY; Zhang Y; Harrison JA; Maier SF; Rice KC; Watkins LR
    Neuroscience; 2009 Dec; 164(4):1821-32. PubMed ID: 19788917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
    Nam S; Kim H; Hong D; Park JB; Kim SJ
    Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers.
    Chandarlapaty S; Sawai A; Ye Q; Scott A; Silinski M; Huang K; Fadden P; Partdrige J; Hall S; Steed P; Norton L; Rosen N; Solit DB
    Clin Cancer Res; 2008 Jan; 14(1):240-8. PubMed ID: 18172276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition.
    Enomoto A; Fukasawa T; Takamatsu N; Ito M; Morita A; Hosoi Y; Miyagawa K
    Eur J Cancer; 2013 Nov; 49(16):3547-58. PubMed ID: 23886587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block.
    Alfano L; Guida T; Provitera L; Vecchio G; Billaud M; Santoro M; Carlomagno F
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3552-7. PubMed ID: 20444924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.
    Dungey FA; Caldecott KW; Chalmers AJ
    Mol Cancer Ther; 2009 Aug; 8(8):2243-54. PubMed ID: 19671736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of RPE cell sterile inflammatory responses and endotoxin-induced uveitis by a cell-impermeable HSP90 inhibitor.
    Qin S; Ni M; Wang X; Maurier-Mahé F; Shurland DL; Rodrigues GA
    Exp Eye Res; 2011 Dec; 93(6):889-97. PubMed ID: 22019372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice.
    Yang R; Tang Q; Miao F; An Y; Li M; Han Y; Wang X; Wang J; Liu P; Chen R
    Int J Nanomedicine; 2015; 10():7345-58. PubMed ID: 26677324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.